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SUMMARY
The possibility of two types of beta-adrenergic receptors
is supported by the results presented. It is shown that
the phenylephrine group of compounds have more pro-
nounced affinities towards the beta,-(cardiac) adrenergic
receptors than towards the beta,-(bronchial) adrenergic
receptors. The cardioselective action is the greatest in the
case of ethylnorphenylephrine. It is postulated that the
presence of a small substituent on the amino nitrogen a"d
a (only one) meta-hydroxyl group may contribute towards
cardioselectivity in the case of phenylethylam;ne deriva-
tives. Ethylnorphenylephrine has a relatively low affinity
towards the alpha-adrenergic receptors.
The nature of the substituent on the amino group of
adrenergic catecholamines is known to have a distinct
influence on the pattern of effects produced by these
compounds. Since two major groups of effects are evident
Ahlquist' postulated two types of adrenergic receptors,
the alpha-adrenergic receptors on which effects are easily
induced by noradrenaline but not by isoproterenol, and
the beta-adrenergic receptors on which effects are easily
induced by isoproterenol but not by noradrenaline.
AI pha-prcperties
HO- OJ'r~-CH2-NH-R R --H Noradrenaline ~ 'l.l
HO- OH -CH 3 Adrenal ine
-CH(CH3)2 Isoproterenol
Beta-properties
Fig. I. De<:rease in alpha-adrenergic properties and in-
crease in beta-adrenergic properties wi th increase in size
of the substituent on the amino group in the noradrenaline
series.
Lands et al.'" and others'·' have recently pointed out
that the beta-adrenergic receptors may further be sub-
divided in two groups, the beta,-receptors and the beta,-
receptors. It was shown that certain beta-adrenergic stimu-
lants, e.g. l-a-methylnoradrenaline (l-nordefrine), act main-
lyon the beta,-receptors causing cardiac stimulatiolol
(positive inotropic and positive chronotropic effects) and
fatty acid mobilization, while other beta-stimulants, e.g.
t-butylnoradrenaline, act mainly on beta,-receptors causing
bronchodilation and vasodilation.
A number of compounds with bronchial selectivity
(beta,-selectivity) have been described recently.'·' Little,
however, has been published on compounds with cardiac
selectivity (beta,-selectivity).
During investigations with a large number of sympa-
thomimetic amines it became evident that the phenyl-
ephrine derivates apparently exhibit the most pronounced
beta,-selectivity of the compounds we investigated. This
article is a report of our findings with this group of
drugs.
'Date received: 31 August 1970.
METHODS
The action of these compounds on the cardiac (beta,)-
receptors were determined by using isolated rat atria
suspended in a modified Locke's solution. The chrono-
tropic effects were measured by means of a Grass force-
displacement transducer connected to a tachograph unit
of a Model 7 Grass Polygraph.
For determination of the effects on the beta,-receptors
relaxation of tracheal chain preparations (of guinea-pigs),
suspended in Krebs-Henseleit solution, were used accord-
ing to the technique described by Foster.'·
The effects of the compounds which were tested for
alpha-receptor affinity, were obtained by using the isolated
vas deferens of young male rats. This preparation was
suspended in Tyrode solution. The temperature through-
out all of these experiments was maintained at 37°C.
Cumulative dose-response curves of the compounds
tested were obtained in each experiment using the method
of Van Rossumn (see Fig. 2), and pD, values and relative
intrinsic activity were calculated from the curves. Each
of these values presented below is an average of at least
6 experiments.
RESULTS
The affinity and intrinsic values of the phenylephrine
derivatives for the beta,- and beta,-receptors, are presented
in Table I. From this table it can be seen that the relative
intrinsic activities of the phenylephrine derivatives (3-
hydroxyphenylamines) are generally slightly lower than
that of noradrenaline on both types of beta-receptors.
Differences in intrinsic activities of the same compound
on the two types of beta-receptors are, however, not
significant.
The differences in affinity (expressed as pD, values in
Table I) of the same compound on the two types of
beta-receptors, however, are significant for phenylephrine,
ethylnorphenylephrine (Effortil) and propylnorphenyl-
ephrine. These three compounds have a markedly better
affinity towards the beta,-receptor, especially ethylnorphe-
nylephrine. The affinities and intrinsic activities of some
3,4-dihydroxyphenylethylamines, 3,5-dihydroxyphenyl-
ethylamines and 4-hydroxyphenylethylamines are alsQ pre-
sented in Table I. Note that those compounds of the last
three series that exhibit higher pD, values on the beta.-
receptors than on the beta,-receptors generally have a
substituent smaller than -c.H. on the amino group.
Since ethylnorphenylephrine exhibited the most pro-
nounced selectivity for the betal-receptors, this compound
was compared with noradrenaline and adrenaline on the
isolated vas deferens of the rat to compare effects on the
alpha-adrenergic receptors. Results of this investigation
are presented in Table 11 and Figs. 2 and 3. Table ill
gives the relative affinities of adrenaline and ethylnorphe-
nylephrine on the alpha-, betal- and beta,-receptors when
the affinities of noradrenaline to these receptors are taken
as 1·0. Note that the affinity of adrenaline is higher than
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TABLE l. RELATIVE INTRINSIC ACTIVITIES AND AFFINITIES (GIVEN AS pD, VALUES) OF 4 SERIES OF ADRENERGIC COMPOUNDS,
TESTED ON THE ISOLATED RAT ATRIUM AND GUINEA-PIG TRACHEAL CHAIN PREPARATION




0·8 5·9 ± 0·1
0·8 6·9 ± 0·1 0·6 5·2 ± 0·2
0·9 8·9 ± 0·3 0·8 5·4 ± 0·3
0·7 7-1 ± 0·4 0·7 5·2 ± 0·2
0·7 5-4 T 0·2 0·7 5·2 ± 0·4
Compound









n. 3, 4-dihydroxyphenethylamine series (adrenaline
series)
















1·0 7-4 ± 0·1 1-0 5-8 ± 0·6
1-0 8·1 ± 0·2 1·0 6·9 ± 0·3
1·0 8·5 ± 0·2 1·0 8·4 ± 0·4
series)
Synephrine R = -eH,
Ethylnorsynephrine R =' -CH,-CHs
Propylnorsynephrine R = -CH,-eH,-CIL
. Butylnorsynephrine R = -eB,-CH,-CH,-CHs






0·8 5·2 ± 0·1 0·6 4·9 ± 0·4
0·8 5·8 ± 0·3 0·7 5·1 ± 0'3
0'7 7·4 ± 0·3 0·9 6·3 ± 0·5










R = -CH-CH - OH














*Values according to Miller. l3
RlA = relative intrinsic activity.
TABLE H. COMPARISON OF EFFECTS OF NORIDRENALINE
ADRE.lI/ALI!'.'E A."D E1HYLNORPHENYLEPHRINE ON ALPHA-RECEMoRS
Alpha-receptor
(rat vas deferens)
Compound STructure RlA pD,
Noradrenaline . O-f·e..,..... 1·0 5·4 ± 0·2
JiO'" OH
Adrenaline no-O-rl a'z"H."" 1-0 5-8 ± 0·3
I'~ . t.ol
Ethylnorphenyl~phrine O,Of''''''''''''''''''' 1-0 4-5 ± 0·2H ' I..
RIA = relative intrinsic activity.




Fig. 2. Cumulative log concentration-response curves for
noradrenaline and ethylnorphenylephrine. Note that
ethylnorphenylephrine exhibits a much higher affinity than
noradrenaline.
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that of noradrenaline on the alpha-receptors, the beta..-
receptors (confirming the results of Ariensll) and also on
the beta,-receptors (confirming the results of Lands et al.').
The difference between the affinities of noradrenaline and
adrenaline is smallest on the alpha-receptors and largest
on the betao-receptors (Lands et al.' also indicated a
larger difference in bronchodilatory activity than in car-
diac activity).







10-6 10-5 10-4 M. concentration
Fig. 3. Cumulative log concentration-response curves for
noradrenaline and ethylnorphenylephrine. Note that
ethylnorphenylephrine exhibits a lower affinity than
noradrenaline.
On the other hand, ethylnorphenylephrine has its high-
est affinity towards the beta,-receptors. It has a lower
affinity than either noradrenaline or adrenaline towards
the alpha-receptors and beta,-receptors.
low activities. Of the phenylephrine derivatives ethylnor-
phenylephrine exhibits the highest degree of electivity
on cardiac rate.
From the results in Table I it appears that two factors
in the series of compounds studied may be responsible
for beta,-receptor selectivity. Firstly, iI is possible that
the 3-hydroxyphenylethylamine (phenylephrine series)
structure is more favourable for affinity towards the betao-
receptors than the 3,4- or 3,5-dihydroxyphenylethylamine
structure or the 4-hydroxyphenylethylamine structure.
Secondly, it appears that the substituent on the amino
group should be smaller than -CJI. to favour affinity
towards the beta,-receptors. The most pronounced exam-
ple in this case is in the phenylephrine series where a -CH,
substituent (in the case of ethylnorphenylephrine) is pre-
sent on the amino group.
Ethylnorphenylephrine also has a relatively low affinity
on the alpha-adrenergic receptors (see Tables 11 and Ill).
The affinity as measured on the beta,-receptors is about
300 times larger than that found on the alpha-receptors.
One would therefore hardly expect any significant alpha-
adrenergic action of this compound in doses that give
a beta,-adrenergic response in the intact animal.
This investigation was supported by grants from the Council
for Scientific and Industrial Research and from South African
Druggists Ltd. The following firms kindly supplied substances
used in this investigation: Boehringer Ingelheim (Pty) Ud
(ethylnorphenylephrine, propylnorphenylephrine. butyl nor-
phenylephrine, ethylnorsynephrine, propylnorsynephrine, butyl-
norsynephrine, isoproterenol, orciprenaline, Th 1165 a, Th
1178 S.U.); Troponwerke Dinklage and Co., Cologne. Germany
(synephrine, butylnorsynephrine, norphenylephrine).
TABLE Ill. RELATIVE AFFINITIES OF NORADRENAlINE, ADRENALINE
AND ETHYLNORPHENYLEPHRINE ON ALPHA- AND BETA-RECEPTORS
Beta-receptors
DISCUSSION
The results indicate that the phenylephrine derivatives are
to a certain extent cardioselective. The only other cardio-
selective compounds of this type are l-nordefrine3 and
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IN DIE VERBYGAAN : PASSING EVENTS
Universily of Cape Town and Association of Surgeons 0/
Sourh Africa (M.A.S.A.), Joint LeclllJ'es. The next meeting wIll
be held on Wednesday 10 March at 5.30 p.m. in the E-floor
Lecture Theatre, Groote Schuur Hospital, Observatory, Cape.
Dr H. Spilg will speak on 'Liver storage'.
Universiteit van Stellenbosch ell Kar! Bremer-hospitaal, Klinies-
paralogiese Besprekings. Die volgende vergadering vind plaas
op Dinsdagmiddag 9 Maart om 4.00 nm. in die Dagkamer.
Iste Vloer, Karl Bremer-hospitaal, Bellville. K.P. Dr. D. S.
Rossouw sal as spreker optree oor 'Vergiftiging'. Alle dokters
wat belang stel word vriendelik uitgenooi om die vergadenng
by te woon.
Kliniese besprekings word ook gereeld om 9.00 vm. elke
Saterdagoggend gehou in die Groot Voorlesingsaal, Kar]
Bremer-hospitaal, en is oop vir bywoning deur dokters.
*
Universireir vall Preroria. Chirurgiese Afdeling, en Preroria Tak
vlln Vereniging 1'1In Chimrge van SlIid-Afrika (M.V.S.A.),
***
University of Cape Town and Croore Schuur Hospira!, Deparr-
l11ent of Derl1l{/{o!ogy, Clinical Lecll/res. The next meeting will
be held on Tuesday 16 March at 4.30 p.m. in the Bennie de
Wet Lecture Theatre. Groote Schuur Hospital, Observatory,
Cape. Dr R. Aron will speak on 'The diagnosis of syphilis'.
South African Insrill/re for Medical Research, Johannesburg,
Swff Scientific Meerings. The next meeting will be held on
Monday 15 March at 5.10 p.m. in the Auditorium. forth
Block, SAIMR. Prof. C. Rosendorff will speak on 'Pyrogen,
salicylate and fever'. All interested persons will be welcome.
**
